Skip to main content
. 2023 Aug 7;34(10):1647–1671. doi: 10.1681/ASN.0000000000000195

Table 1.

Clinical information of human subjects

Variable Control (n=18) CKD (n=18)
Age (yr) 47.00±11.79 48.83±9.82
Sex (Female/Male) 9/9 8/10
Hematuria (n) 0 10
Proteinuria (g/24 h) 2.55±1.66
SBP (mm Hg) 112.33±7.33 149.94±7.67a
DBP (mm Hg) 77.27±5.16 102.16±8.46a
RBC (1012/L) 4.95±0.32a 3.06±0.95a
Hb (g/L) 144.83±12.34 89.11±28.04a
HCT (%) 42.88±3.04 27.37±8.47a
TP (g/L) 70.83±4.24 58.79±8.51a
ALB (g/L) 45.44±1.82 30.47±7.47a
GLO (g/L) 29.52±3.59 28.31±3.81
BUN (mmol/L) 4.72±1.28 18.33±11.99a
Scr (μmol/L) 70.75±11.10 548.85±227.66a
eGFR 97.18±9.38 12.30±9.27a
Etiology
Chronic GN (n) 8
Diabetes (n) 6
Hypertension (n) 4
Medications
Antihypertensive drugs (n) 14
Antianemia drugs (n) 9

Data were expressed as mean±SD. P values of age, RBC, Hb, HCT, TP, ALB, BUN, Scr, and eGFR were assessed using two-tailed unpaired t test with Welch correlation; P value of SBP, DBP, and GLO were assessed using two-tailed unpaired t test. SBP, systolic BP; DBP, diastolic BP; RBC, red blood cell; Hb, hemoglobin; HCT, hematocrit; TP, total serum protein; ALB, serum albumin; GLO, serum globulin; Scr, serum creatinine.

a P < 0.05.